Trends in Cardiovascular Medicine
Volume 18, Issue 7 , Pages 247-253, October 2008

Endothelial Nicotinic Acetylcholine Receptors and Angiogenesis

  • John P. Cooke

      Affiliations

    • Corresponding Author InformationAddress correspondence to: John P. Cooke, Division of Cardiovascular Medicine, Stanford University, School of Medicine, 300 Pasteur Drive, Falk CVRC, Stanford, CA 94305-5406, USA. Tel.: (+1) 650-723-6141; fax: (+1) 650-725-1599
    • Dr. Cooke is an inventor on patents owned by Stanford University (Stanford, CA) related to the therapeutic uses of the nicotinic acetylcholine receptor pathway for angiogenesis, and has received royalty payments and equity for licencing of the intellectual property.
    • ,
  • Yohannes T. Ghebremariam

Division of Cardiovascular Medicine, Stanford University, Stanford, CA 94305, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1050-1738(08)00130-8

doi:10.1016/j.tcm.2008.11.007

Trends in Cardiovascular Medicine
Volume 18, Issue 7 , Pages 247-253, October 2008

Article Tools

* Image Usage & Resolution